STAAR Surgical Co Cost, Depreciation
STAAR Surgical Co (STAA) reported Cost, Depreciation of $936.00 thousand for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSoldDepreciation · last filed 2026-08-12
- STAAR Surgical Co cost, depreciation for the quarter ending 2026-07-03 was $936.00K, a 21.24% increase year-over-year.
- STAAR Surgical Co cost, depreciation for the quarter ending 2026-04-03 was $875.00K, a 0.81% increase year-over-year.
- STAAR Surgical Co cost, depreciation for the quarter ending 2026-01-02 was $778.00K, a 13.94% decline year-over-year.
- STAAR Surgical Co cost, depreciation for the quarter ending 2025-09-26 was $750.00K, a 27.99% increase year-over-year.
- STAAR Surgical Co cost, depreciation for fiscal 2026 was $3.17M, a 25.81% increase from fiscal 2024.
- STAAR Surgical Co cost, depreciation for fiscal 2024 was $2.52M, a 79.22% increase from fiscal 2023.
- STAAR Surgical Co cost, depreciation for fiscal 2023 was $1.41M, a 20.39% increase from fiscal 2022.
- STAAR Surgical Co cost, depreciation for fiscal 2022 was $1.17M.
| Period end | Cost, Depreciation 3 month | Cost, Depreciation 6 month | Cost, Depreciation 9 month | Cost, Depreciation 12 month |
|---|---|---|---|---|
| 2026-07-03 | $936.00K 10-Q · filed 2026-08-12 | $1.81M 10-Q · filed 2026-08-12 | $2.59M derived: sum of 3 quarters · filed 2026-08-12 | $3.34M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $875.00K 10-Q · filed 2026-05-13 | $1.65M derived: sum of 2 quarters · filed 2026-05-13 | $2.40M derived: sum of 3 quarters · filed 2026-05-13 | $3.17M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.53M derived: sum of 2 quarters · filed 2026-03-03 | $2.30M derived: sum of 3 quarters · filed 2026-08-12 | $3.17M 10-K · filed 2026-03-03 |
| 2025-09-26 | $750.00K 10-Q · filed 2025-11-05 | $1.52M derived: sum of 2 quarters · filed 2026-08-12 | $2.39M 10-Q · filed 2025-11-05 | $3.29M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $772.00K 10-Q · filed 2026-08-12 | $1.64M 10-Q · filed 2026-08-12 | $2.54M derived: sum of 3 quarters · filed 2026-08-12 | $3.13M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $868.00K 10-Q · filed 2026-05-13 | $1.77M derived: sum of 2 quarters · filed 2026-05-13 | $2.36M derived: sum of 3 quarters · filed 2026-05-13 | $2.94M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.49M derived: sum of 2 quarters · filed 2026-03-03 | $2.07M derived: sum of 3 quarters · filed 2026-03-03 | $2.52M 10-K · filed 2026-03-03 |
| 2024-09-27 | $586.00K 10-Q · filed 2025-11-05 | $1.17M derived: sum of 2 quarters · filed 2025-11-05 | $1.61M 10-Q · filed 2025-11-05 | |
| 2024-06-28 | $582.00K 10-Q · filed 2025-08-06 | $1.03M 10-Q · filed 2025-08-06 | ||
| 2024-03-29 | $446.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-29 | $1.41M 10-K · filed 2026-03-03 | |||
| 2022-12-30 | $1.17M 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |